Silencing of the negative-limb regulator DEC2, a purported intermediary between circadian rhythm and tumor progression, enhanced the viability, invasiveness, and colony-forming potential of breast cancer samples [32]. This evidence concerns the gene BHLHE41 and breast cancer.